OTC Markets OTCPK - Delayed Quote USD

JD Health International Inc. (JDHIY)

Compare
3.8100 +3.8100 (0.00%)
At close: November 15 at 3:00 PM EST
Loading Chart for JDHIY
DELL
  • Previous Close 3.8100
  • Open 3.8100
  • Bid 3.2300 x 40000
  • Ask 3.9000 x --
  • Day's Range 3.8100 - 3.8100
  • 52 Week Range 3.2004 - 5.0000
  • Volume 100
  • Avg. Volume 1
  • Market Cap (intraday) 12.156B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) 31.75
  • EPS (TTM) 0.1200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

ir.jdhealth.com

3,177

Full Time Employees

December 31

Fiscal Year Ends

Recent News: JDHIY

View More

Performance Overview: JDHIY

Trailing total returns as of 11/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

JDHIY
23.80%
HANG SENG INDEX
14.84%

1-Year Return

JDHIY
23.80%
HANG SENG INDEX
12.16%

3-Year Return

JDHIY
49.20%
HANG SENG INDEX
13.00%

5-Year Return

JDHIY
49.20%
HANG SENG INDEX
13.00%

Compare To: JDHIY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: JDHIY

View More

Valuation Measures

Annual
As of 11/15/2024
  • Market Cap

    11.32B

  • Enterprise Value

    4.72B

  • Trailing P/E

    32.80

  • Forward P/E

    23.31

  • PEG Ratio (5yr expected)

    0.98

  • Price/Sales (ttm)

    1.59

  • Price/Book (mrq)

    1.69

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    10.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.78%

  • Return on Assets (ttm)

    0.77%

  • Return on Equity (ttm)

    5.19%

  • Revenue (ttm)

    54.76B

  • Net Income Avi to Common (ttm)

    2.62B

  • Diluted EPS (ttm)

    0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.92B

  • Total Debt/Equity (mrq)

    0.42%

  • Levered Free Cash Flow (ttm)

    3.92B

Research Analysis: JDHIY

View More

Company Insights: JDHIY

Research Reports: JDHIY

View More

People Also Watch